Corient Private Wealth’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.49M Sell
471,938
-86,286
-15% -$1.34M 0.01% 737
2026
Q1
$7.53M Buy
558,224
+101,939
+22% +$1.43M 0.01% 718
2025
Q4
$5.68M Sell
456,285
-9,831
-2% -$106K 0.01% 727
2025
Q3
$4.61M Buy
466,116
+40,329
+9% +$393K 0.01% 745
2025
Q2
$3.8M Sell
425,787
-42,637
-9% -$360K 0.01% 790
2025
Q1
$4.08M Sell
468,424
-198,330
-30% -$2.08M 0.01% 740
2024
Q4
$8.3M Sell
666,754
-15,829
-2% -$195K 0.01% 561
2024
Q3
$7.92M Buy
682,583
+97,300
+17% +$1.12M 0.01% 622
2024
Q2
$6.22M Sell
585,283
-150,957
-21% -$1.67M 0.01% 648
2024
Q1
$8.79M Buy
736,240
+74,378
+11% +$896K 0.02% 561
2023
Q4
$7.17M Sell
661,862
-26,699
-4% -$256K 0.01% 608
2023
Q3
$6.79M Buy
688,561
+210,115
+44% +$2.19M 0.02% 568
2023
Q2
$4.78M Buy
478,446
+214,716
+81% +$2.05M 0.01% 641
2023
Q1
$2.54M Buy
263,730
+174,340
+195% +$1.93M 0.01% 769
2022
Q4
$995K Buy
+89,390
New +$934K ﹤0.01% 918

Other funds holding VTRS

Corient Private Wealth's VTRS Position: Q2 2026 in Review

Corient Private Wealth reduced its Viatris (VTRS) stake by 15% in Q2 2026, selling an estimated $1.34M and leaving 471,938 shares worth $7.49M. The position accounts for 0.01% of the portfolio, ranked #737.

Corient Private Wealth first reported a position in VTRS in Q4 2022 and has held it in 15 quarters since. The position peaked at $8.79M in Q1 2024. 1,030 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Corient Private Wealth held 471,938 shares of Viatris worth $7.49M as of Q2 2026.
  • Corient Private Wealth sold 86,286 Viatris shares in Q2 2026, an estimated $1.34M.
  • Viatris made up 0.01% of Corient Private Wealth's portfolio in Q2 2026, its #737 holding.
  • Corient Private Wealth first reported a position in Viatris in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Viatris position peaked at $8.79M in Q1 2024.
  • 1,030 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.